Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments
- 1 July 2014
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 235 (1) , 81-83
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient educationJournal of Clinical Lipidology, 2013
- Association Between Persistence with Statin Therapy and Reduction in Low‐Density Lipoprotein Cholesterol Level: Analysis of Real‐Life Data from Community SettingsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Adherence to preventive statin therapy according to socioeconomic positionEuropean Journal of Clinical Pharmacology, 2013
- Patient Characteristics Associated with Medication AdherenceClinical Medicine & Research, 2013
- Persistence with statin therapy in HungaryArchives of Medical Science, 2013
- Predictors of Statin AdherenceCurrent Cardiology Reports, 2011
- Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort studyBMC Cardiovascular Disorders, 2011
- Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage studyEuropean Journal of Clinical Pharmacology, 2010
- The effects of adherence and persistence on clinical outcomes in patients treated with statins: A systematic reviewJournal of Clinical Lipidology, 2010
- Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in ItalyEuropean Journal of Clinical Pharmacology, 2008